Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Am J Infect Control ; 49(11): 1443-1444, 2021 11.
Article in English | MEDLINE | ID: mdl-34416314

ABSTRACT

We instituted Personal Protective Equipment (PPE) Monitors as part of our care of COVID-19 patients in high-risk zones. PPE Monitors aided health care personnel (HCP) in donning and doffing, which contributed to nearly zero transmission of COVID-19 to HCP, despite their care of over 1400 COVID-19 patients.


Subject(s)
COVID-19 , Personal Protective Equipment , Health Personnel , Humans , Infection Control , Infectious Disease Transmission, Patient-to-Professional , SARS-CoV-2
3.
Infect Control Hosp Epidemiol ; 26(3): 273-80, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15796280

ABSTRACT

BACKGROUND AND OBJECTIVE: Fluoroquinolones have not been frequently implicated as a cause of Clostridium difficile outbreaks. Nosocomial C. difficile infections increased from 2.7 to 6.8 cases per 1000 discharges (P < .001). During the first 2 years of the outbreak, there were 253 nosocomial C. difficile infections; of these, 26 resulted in colectomy and 18 resulted in death. We conducted an investigation of a large C. difficile outbreak in our hospital to identify risk factors and characterize the outbreak. METHODS: A retrospective case-control study of case-patients with C. difficile infection from January 2000 through April 2001 and control-patients matched by date of hospital admission, type of medical service, and length of stay; an analysis of inpatient antibiotic use; and antibiotic susceptibility testing and molecular subtyping of isolates were performed. RESULTS: On logistic regression analysis, clindamycin (odds ratio [OR], 4.8; 95% confidence interval [CI95], 1.9-12.0), ceftriaxone (OR, 5.4; CI95, 1.8-15.8), and levofloxacin (OR, 2.0; CI95, 1.2-3.3) were independently associated with infection. The etiologic fractions for these three agents were 10.0%, 6.7%, and 30.8%, respectively. Fluoroquinolone use increased before the onset of the outbreak (P < .001); 59% of case-patients and 41% of control-patients had received this antibiotic class. The outbreak was polyclonal, although 52% of isolates belonged to two highly related molecular subtypes. CONCLUSIONS: Exposure to levofloxacin was an independent risk factor for C. difficile-associated diarrhea and appeared to contribute substantially to the outbreak. Restricted use of levofloxacin and the other implicated antibiotics may be required to control the outbreak


Subject(s)
Clostridioides difficile/isolation & purification , Cross Infection/microbiology , Disease Outbreaks , Enterocolitis, Pseudomembranous/prevention & control , Fluoroquinolones/therapeutic use , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Case-Control Studies , Cause of Death , Clindamycin/adverse effects , Clindamycin/therapeutic use , Cross Infection/epidemiology , Diarrhea/chemically induced , Diarrhea/microbiology , Enterocolitis, Pseudomembranous/mortality , Female , Fluoroquinolones/adverse effects , Hospitals, Teaching , Humans , Levofloxacin , Logistic Models , Male , Ofloxacin/adverse effects , Ofloxacin/therapeutic use , Pennsylvania/epidemiology , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL